Personal information

No personal information available

Activities

Employment (1)

Institut Pasteur: Paris, Ile de France, FR

2012-01-03 to present | Experienced Research Engineer (Structural Virology )
Employment
Source: Self-asserted source
Annalisa Meola

Works (45)

Heterodimer of poxvirus A16 and G9 proteins as an immunogen

2024-11-21 | Patent
PAT:

WO2024236192

Contributors: Annalisa Meola; Schwartz O; Hubert M; Lafaye P; Guardado-Calvo P
Source: Self-asserted source
Annalisa Meola

MPXV Infection Stimulates a More Robust and Durable Neutralizing Antibody Response Compared to MVA-BN Vaccination.

The Journal of infectious diseases
2024-10 | Journal article
Contributors: Selverian CN; Monticelli SR; Jaleta YM; Lasso G; DeMouth ME; Meola A; Berrigan J; Batchelor TG; Battini L; Guardado-Calvo P et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Mechanisms of Tecovirimat Antiviral Activity and Poxvirus Resistance

2024-09 | Preprint
Contributors: Vernuccio R; León AM; Poojari C; Buchrieser J; Selverian C; Jaleta Y; Meola A; Guivel-Benhassine F; Porrot F; Haouz A et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Modulation of SARS-CoV-2 spike binding to ACE2 through conformational selection

2024-03-18 | Preprint
Contributors: Prithwidip Saha; Ignacio Fernanadez; Fidan Sumbul; Claire Valotteau; Dorota Kostrz; Annalisa Meola; Eduard Baquero; Arvind Sharma; James R. Portman; Francois Stransky et al.
Source: check_circle
Crossref

Production and Purification of Hantavirus Glycoproteins in Drosophila melanogaster S2 Cells.

Methods in molecular biology (Clifton, N.J.)
2024-01 | Journal article
Contributors: Meola A; Guardado-Calvo P
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

TMPRSS2 is a functional receptor for human coronavirus HKU1.

Nature
2023-10 | Journal article
Contributors: Saunders N; Fernandez I; Planchais C; Michel V; Rajah MM; Baquero Salazar E; Postal J; Porrot F; Guivel-Benhassine F; Blanc C et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

A synthetic delivery vector for mucosal vaccination.

Biomaterials
2023-09 | Journal article
Contributors: Billet A; Hadjerci J; Tran T; Kessler P; Ulmer J; Mourier G; Ghazarian M; Gonzalez A; Thai R; Urquia P et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals.

Immunity
2023-08 | Journal article
Contributors: Sokal A; Barba-Spaeth G; Hunault L; Fernández I; Broketa M; Meola A; Fourati S; Azzaoui I; Vandenberghe A; Lagouge-Roussey P et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics

JCI Insight
2023-07-10 | Journal article
Contributors: Matteo Broketa; Aurélien Sokal; Michael Mor; Pablo Canales-Herrerias; Angga Perima; Annalisa Meola; Ignacio Fernández; Bruno Iannascoli; Guilhem Chenon; Alexis Vandenberghe et al.
Source: check_circle
Crossref

Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France

Open Forum Infectious Diseases
2023-07-01 | Journal article
Part of ISSN: 2328-8957
Contributors: Alix De Thoisy; Tom Woudenberg; Stéphane Pelleau; Françoise Donnadieu; Laura Garcia; Laurie Pinaud; Laura Tondeur; Annalisa Meola; Laurence Arowas; Nathalie Clement et al.
Source: Self-asserted source
Annalisa Meola

Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant.

Immunity
2022-04 | Journal article
Contributors: Sokal A; Broketa M; Barba-Spaeth G; Meola A; Fernández I; Fourati S; Azzaoui I; de La Selle A; Vandenberghe A; Roeser A et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Microbial Protein Binding to gC1qR Drives PLA2G1B-Induced CD4 T-Cell Anergy.

Frontiers in immunology
2022-03 | Journal article
Contributors: Pothlichet J; Meola A; Bugault F; Jeammet L; Savitt AG; Ghebrehiwet B; Touqui L; Pouletty P; Fiore F; Sauvanet A et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.

The Journal of infectious diseases
2021-11 | Journal article
Contributors: Pelleau S; Woudenberg T; Rosado J; Donnadieu F; Garcia L; Obadia T; Gardais S; Elgharbawy Y; Velay A; Gonzalez M et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants.

Immunity
2021-09 | Journal article
Contributors: Sokal A; Barba-Spaeth G; Fernández I; Broketa M; Azzaoui I; de La Selle A; Vandenberghe A; Fourati S; Roeser A; Meola A et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.

Cell
2021-02 | Journal article
Contributors: Sokal A; Chappert P; Barba-Spaeth G; Roeser A; Fourati S; Azzaoui I; Vandenberghe A; Fernandez I; Meola A; Bouvier-Alias M et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study.

The Lancet. Microbe
2020-12 | Journal article
Contributors: Rosado J; Pelleau S; Cockram C; Merkling SH; Nekkab N; Demeret C; Meola A; Kerneis S; Terrier B; Fafi-Kremer S et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

PLA2G1B is involved in CD4 anergy and CD4 lymphopenia in HIV-infected patients.

The Journal of clinical investigation
2020-06 | Journal article
Contributors: Pothlichet J; Rose T; Bugault F; Jeammet L; Meola A; Haouz A; Saul F; Geny D; Alcami J; Ruiz-Mateos E et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

The Ancient Gamete Fusogen HAP2 Is a Eukaryotic Class II Fusion Protein.

Cell
2017-02 | Journal article
Contributors: Fédry J; Liu Y; Péhau-Arnaudet G; Pei J; Li W; Tortorici MA; Traincard F; Meola A; Bricogne G; Grishin NV et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies.

Journal of virology
2014-12 | Journal article
Contributors: Meola A; Tarr AW; England P; Meredith LW; McClure CP; Foung SK; McKeating JA; Ball JK; Rey FA; Krey T
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Robust and low cost uniform (15)N-labeling of proteins expressed in Drosophila S2 cells and Spodoptera frugiperda Sf9 cells for NMR applications.

Journal of structural biology
2014-08 | Journal article
Contributors: Meola A; Deville C; Jeffers SA; Guardado-Calvo P; Vasiliauskaite I; Sizun C; Girard-Blanc C; Malosse C; van Heijenoort C; Chamot-Rooke J et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission.

Hepatology (Baltimore, Md.)
2013-07 | Journal article
Contributors: Tarr AW; Lafaye P; Meredith L; Damier-Piolle L; Urbanowicz RA; Meola A; Jestin JL; Brown RJ; McKeating JA; Rey FA et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.

PLoS pathogens
2013-05 | Journal article
Contributors: Krey T; Meola A; Keck ZY; Damier-Piolle L; Foung SK; Rey FA
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.

Science translational medicine
2012-01 | Journal article
Contributors: Colloca S; Barnes E; Folgori A; Ammendola V; Capone S; Cirillo A; Siani L; Naddeo M; Grazioli F; Esposito ML et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Chimpanzee adenovirus vaccine carriers

2011-11 | Patent
OTHER-ID:

AU2011247887

Contributors: AGOSTINO CIRILLO; ALFREDO NICOSIA; STEFANNO COLLOCA; BRUNI ERCOLE BRUNO; ELISABETTA SPORENO; ANNALISA MEOLA
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Isolation of Fully Human Antagonistic RON Antibodies Showing Efficient Block of Downstream Signaling and Cell Migration.

Translational oncology
2011-02 | Journal article
Contributors: Gunes Z; Zucconi A; Cioce M; Meola A; Pezzanera M; Acali S; Zampaglione I; De Pratti V; Bova L; Talamo F et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer.

Journal of oncology
2009-01 | Journal article
Contributors: Ansuini H; Meola A; Gunes Z; Paradisi V; Pezzanera M; Acali S; Santini C; Luzzago A; Mori F; Lazzaro D et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates.

Journal of immunology (Baltimore, Md. : 1950)
2006-11 | Journal article
Contributors: Capone S; Zampaglione I; Vitelli A; Pezzanera M; Kierstead L; Burns J; Ruggeri L; Arcuri M; Cappelletti M; Meola A et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.

Journal of virology
2006-02 | Journal article
Contributors: Capone S; Meola A; Ercole BB; Vitelli A; Pezzanera M; Ruggeri L; Davies ME; Tafi R; Santini C; Luzzago A et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

Nature medicine
2006-02 | Journal article
Contributors: Folgori A; Capone S; Ruggeri L; Meola A; Sporeno E; Ercole BB; Pezzanera M; Tafi R; Arcuri M; Fattori E et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses.

Journal of biosciences
2003-04 | Journal article
Contributors: Mondelli MU; Cerino A; Meola A; Nicosia A
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.

Journal of virology
2003-02 | Journal article
Contributors: Roccasecca R; Ansuini H; Vitelli A; Meola A; Scarselli E; Acali S; Pezzanera M; Ercole BB; McKeating J; Yagnik A et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes

Molecular Immunology
2001-12 | Journal article
Part of ISSN: 0161-5890
Contributors: Rosamaria Roccasecca; Antonella Folgori; Bruno Bruni Ercole; Giulia Puntoriero; Armin Lahm; Silvia Zucchelli; Rosalba Tafi; Monica Pezzanera; Giovanni Galfre; Anna Tramontano et al.
Source: Self-asserted source
Annalisa Meola

Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain?

Antiviral Research
2001-11 | Journal article
Part of ISSN: 0166-3542
Contributors: Mario U Mondelli; Antonella Cerino; Laura Segagni; Annalisa Meola; Agostino Cividini; Enrico Silini; Alfredo Nicosia
Source: Self-asserted source
Annalisa Meola

Monoclonal Antibodies with Broad Specificity for Hepatitis C Virus Hypervariable Region 1 Variants Can Recognize Viral Particles

The Journal of Immunology
2001-10-01 | Journal article
Part of ISSN: 0022-1767
Part of ISSN: 1550-6606
Contributors: Antonella Cerino; Annalisa Meola; Laura Segagni; Milena Furione; Sabrina Marciano; Miriam Triyatni; T. Jake Liang; Alfredo Nicosia; Mario U. Mondelli
Source: Self-asserted source
Annalisa Meola

Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization

Hepatology
2001-03 | Journal article
Part of ISSN: 0270-9139
Contributors: S Zucchelli
Source: Self-asserted source
Annalisa Meola

Induction of Cross-reactive Humoral Immune Response by Immunization with Mimotopes of the Hypervariable Region 1 of the Hepatitis C Virus

International Reviews of Immunology
2001-01 | Journal article
Part of ISSN: 0883-0185
Part of ISSN: 1563-5244
Contributors: Rosamaria Roccasecca; Antonella Folgori; Bruno Bruni Ercole; Giulia Puntoriero; Armin Lahm; Silvia Zucchelli; Rosalba Tafi; Monica Pezzanera; Giovanni Galfre; Anna Tramontano et al.
Source: Self-asserted source
Annalisa Meola

A model for the hepatitis C virus envelope glycoprotein E2

Proteins: Structure, Function, and Genetics
2000-08-15 | Journal article
Part of ISSN: 0887-3585
Part of ISSN: 1097-0134
Contributors: Asutosh T. Yagnik; Armin Lahm; Annalisa Meola; Rosa Maria Roccasecca; Bruno B. Ercole; Alfredo Nicosia; Anna Tramontano
Source: Self-asserted source
Annalisa Meola

Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.

Journal of virology
2000-07 | Journal article
Contributors: Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C et al.
Source: Self-asserted source
Annalisa Meola via Europe PubMed Central

Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation

Hepatology
1999-08 | Journal article
Part of ISSN: 0270-9139
Contributors: Mario U. Mondelli; Antonella Cerino; Antonella Lisa; Sabrina Brambilla; Laura Segagni; Agostino Cividini; Morena Bissolati; Gabriele Missale; Giorgio Bellati; Annalisa Meola et al.
Source: Self-asserted source
Annalisa Meola

Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1can induce antibodies cross-reacting with a large number of viral variants

The EMBO Journal
1998-07-01 | Journal article
Part of ISSN: 1460-2075
Contributors: G. Puntoriero
Source: Self-asserted source
Annalisa Meola

Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration

Vaccine
1997-08 | Journal article
Part of ISSN: 0264-410X
Contributors: P DELMASTRO
Source: Self-asserted source
Annalisa Meola

Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients.

Journal of immunology (Baltimore, Md. : 1950)
1996-06-01 | Journal article
PMID: 8666827
Contributors: Prezzi C; Nuzzo M; Meola A; Delmastro P; Galfrè G; Cortese R; Nicosia A; Monaci P
Source: Self-asserted source
Annalisa Meola

Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.

Journal of immunology (Baltimore, Md. : 1950)
1995-04-01 | Journal article
PMID: 7534789
Contributors: Meola A; Delmastro P; Monaci P; Luzzago A; Nicosia A; Felici F; Cortese R; Galfrè G
Source: Self-asserted source
Annalisa Meola

Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library

Gene
1994-09 | Journal article
Part of ISSN: 0378-1119
Contributors: Corradino Motti; Maurizio Nuzzo; Annalisa Meola; Giovanni Galfré; Franco Felici; Riccardo Cortese; Alfredo Nicosia; Paolo Monaci
Source: Self-asserted source
Annalisa Meola

A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera.

The EMBO journal
1994-05-01 | Journal article
PMID: 7514533
Contributors: Folgori A; Tafi R; Meola A; Felici F; Galfré G; Cortese R; Monaci P; Nicosia A
Source: Self-asserted source
Annalisa Meola